Eli Lilly takes aim at illicit market for its experimental weight-loss drug
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
Watch CBS News
Daniel Gilbert is an investigative reporter for CBS News based in Washington, D.C.
He previously worked for The Washington Post, The Seattle Times and The Wall Street Journal. His reporting for the Bristol Herald Courier received the 2010 Pulitzer Prize for Public Service.
He can be reached on the encrypted messaging app Signal at bydanielgilbert.08.
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
A federal judge sentenced the owner of a peptide company to nearly six years in prison after finding the business deceived customers and sold products that were adulterated with steroids.
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.
Doctors are jumping the gun to prescribe a medication lacking FDA approval that has gone viral on social media. "Why are we waiting?" one physician asked.
President Trump picked Dr. Nicole Saphier as his new nominee for surgeon general, and blamed Republican Sen. Bill Cassidy for Casey Mean's nomination stalling in the Senate.